<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml>
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="0" size="22" family="Times" color="#000000"/>
	<fontspec id="1" size="8" family="Times" color="#000000"/>
	<fontspec id="2" size="7" family="Times" color="#000000"/>
<text top="26" left="55" width="517" height="27" font="0"><b>ENCODE DCC Antibody Validation Document</b></text>
<text top="77" left="48" width="81" height="12" font="1">Date of Submission</text>
<text top="347" left="39" width="41" height="12" font="1">Antibody </text>
<text top="359" left="39" width="52" height="12" font="1">Description: </text>
<text top="371" left="39" width="2" height="12" font="1"> </text>
<text top="485" left="84" width="61" height="12" font="1">Species Target</text>
<text top="521" left="84" width="90" height="12" font="1">Validation Method #1</text>
<text top="134" left="291" width="25" height="12" font="1">Email:</text>
<text top="134" left="48" width="27" height="12" font="1">Name:</text>
<text top="215" left="48" width="68" height="12" font="1">Antibody Name:</text>
<text top="215" left="300" width="29" height="12" font="1">Target:</text>
<text top="170" left="192" width="15" height="12" font="1">Lab</text>
<text top="249" left="183" width="44" height="12" font="1">Company/</text>
<text top="261" left="183" width="31" height="12" font="1">Source:</text>
<text top="485" left="300" width="53" height="12" font="1">Species Host</text>
<text top="300" left="336" width="50" height="12" font="1">Lot Number</text>
<text top="294" left="39" width="172" height="12" font="1">Catalog Number, database ID, laboratory </text>
<text top="306" left="39" width="2" height="12" font="1"> </text>
<text top="521" left="300" width="90" height="12" font="1">Validation Method #2</text>
<text top="555" left="84" width="50" height="12" font="1">Purification </text>
<text top="567" left="84" width="33" height="12" font="1">Method</text>
<text top="555" left="300" width="48" height="12" font="1">Polyclonal/ </text>
<text top="567" left="300" width="50" height="12" font="1">Monoclonal</text>
<text top="626" left="30" width="58" height="12" font="1">Reference (PI/</text>
<text top="638" left="30" width="49" height="12" font="1">Publication </text>
<text top="650" left="30" width="52" height="12" font="1">Information)</text>
<text top="674" left="28" width="294" height="12" font="1">Please complete the following for antibodies to histone modifications: </text>
<text top="687" left="28" width="205" height="11" font="2">if your specifications are not listed in the drop-down box,  </text>
<text top="697" left="28" width="155" height="11" font="2">please write-in the appropriate information</text>
<text top="728" left="30" width="59" height="12" font="1">Histone Name</text>
<text top="728" left="156" width="52" height="12" font="1">AA modified</text>
<text top="728" left="327" width="48" height="12" font="1">AA Position</text>
<text top="728" left="444" width="53" height="12" font="1">Modification</text>
<text top="419" left="39" width="29" height="12" font="1">Target </text>
<text top="431" left="39" width="52" height="12" font="1">Description: </text>
<text top="443" left="39" width="2" height="12" font="1"> </text>
<text top="599" left="165" width="51" height="12" font="1">Vendor URL:</text>
<text top="601" left="238" width="189" height="12" font="1">lhttp://www.scbt.com/datasheet-476-stat2-c-</text>
<text top="613" left="238" width="73" height="12" font="1">20-antibody.html</text>
<text top="77" left="138" width="27" height="12" font="1">1/4/12</text>
<text top="340" left="95" width="136" height="12" font="1">rabbit polyclonal IgG, 200 µg/ml </text>
<text top="352" left="95" width="253" height="12" font="1">epitope mapping at the C-terminus of Stat2 of human origin </text>
<text top="364" left="95" width="244" height="12" font="1">recommended for detection of Stat2 p113 of human origin</text>
<text top="484" left="150" width="31" height="12" font="1">Human</text>
<text top="520" left="178" width="89" height="12" font="2">Immunoprecipitation</text>
<text top="134" left="326" width="92" height="12" font="1">sglandt@stanford.edu</text>
<text top="134" left="83" width="61" height="12" font="1">Stephen Landt</text>
<text top="214" left="121" width="123" height="12" font="1"> Stat2 (C-20) Antibody: sc-476</text>
<text top="214" left="339" width="118" height="12" font="1">STAT2  (EntrezGene ID 6773)</text>
<text top="170" left="230" width="29" height="12" font="1">Snyder</text>
<text top="255" left="239" width="107" height="12" font="1">Santa Cruz Biotechnology</text>
<text top="484" left="361" width="27" height="12" font="1">Rabbit</text>
<text top="300" left="395" width="26" height="12" font="1">B1908</text>
<text top="300" left="215" width="27" height="12" font="1">sc-476</text>
<text top="520" left="395" width="19" height="12" font="2">ChIP</text>
<text top="561" left="141" width="30" height="12" font="2">Affinity</text>
<text top="561" left="356" width="43" height="12" font="2">Polyclonal</text>
<text top="412" left="95" width="418" height="12" font="1">Signal transducer and activator of transcription that mediates signaling by type I IFNs (IFN-alpha and </text>
<text top="424" left="95" width="440" height="12" font="1">IFN-beta). Following type I IFN binding to cell surface receptors, Jak kinases (TYK2 and JAK1) are activated, </text>
<text top="436" left="95" width="433" height="12" font="1">leading to tyrosine phosphorylation of STAT1 and STAT2. The phosphorylated STATs dimerize, associate </text>
<text top="448" left="95" width="449" height="12" font="1">with ISGF3G/IRF-9 to form a complex termed ISGF3 transcription factor, that enters the nucleus. ISGF3 binds </text>
<text top="460" left="95" width="440" height="12" font="1">to the IFN stimulated response element (ISRE) to activate the transcription of interferon stimulated genes, </text>
<text top="472" left="95" width="141" height="12" font="1">which drive the cell in an antiviral </text>
<text top="484" left="95" width="20" height="12" font="1">state</text>
</page>
<page number="2" position="absolute" top="0" left="0" height="792" width="612">
<text top="146" left="52" width="57" height="12" font="1">Validation #1 </text>
<text top="158" left="52" width="34" height="12" font="1">Analysis</text>
<text top="661" left="50" width="143" height="12" font="1">Insert Validation Image (click here)</text>
<text top="43" left="125" width="418" height="12" font="1">Comment: A single band consistent with the size expected for STAT2 (~113kD, indicated by arrow) is </text>
<text top="55" left="125" width="418" height="12" font="1">observed in material immunoprecipitated from HeLa S3 lysates using sc-476.  This  band is efficiently </text>
<text top="67" left="125" width="378" height="12" font="1">and specifically  immunoprecipitated.   Therefore, sc-476 meets this criterion for validation. </text>
</page>
<page number="3" position="absolute" top="0" left="0" height="612" width="792">
	<fontspec id="3" size="10" family="Times" color="#000000"/>
	<fontspec id="4" size="26" family="Times" color="#000000"/>
	<fontspec id="5" size="22" family="Times" color="#000000"/>
	<fontspec id="6" size="8" family="Times" color="#000000"/>
	<fontspec id="7" size="7" family="Times" color="#ffffff"/>
<text top="373" left="56" width="660" height="13" font="3">Immunoprecipitation of STAT2 from HeLa S3 cells using sc-476.  Lanes 1-3; material immunoprecipitated with sc-476, lanes </text>
<text top="387" left="56" width="680" height="13" font="3">4-6: material immunoprecipitated using control IgG.  1ug of antibody was used for immunoprecipitations in lanes 1 and 4, 2ug in </text>
<text top="401" left="56" width="546" height="13" font="3">lanes 2 and 5, 4 ug in lanes 3 and 6.  Arrow indicates band consistent with the expected size of STAT2.</text>
<text top="402" left="602" width="3" height="11" font="1"> </text>
<text top="77" left="281" width="194" height="31" font="4">sc-476 (STAT2) </text>
<text top="110" left="251" width="252" height="31" font="4">Immunoprecipitation </text>
<text top="144" left="371" width="7" height="27" font="5"> </text>
<text top="332" left="329" width="8" height="11" font="6"><b>3 </b></text>
<text top="332" left="219" width="29" height="11" font="6"><b>Lane: </b></text>
<text top="167" left="339" width="43" height="11" font="6"><b>MW (kD) </b></text>
<text top="182" left="348" width="18" height="10" font="7"><b>150 </b></text>
<text top="203" left="348" width="18" height="10" font="7"><b>100 </b></text>
<text top="219" left="350" width="13" height="10" font="7"><b>75 </b></text>
<text top="240" left="350" width="13" height="10" font="7"><b>50 </b></text>
<text top="273" left="350" width="13" height="10" font="7"><b>38 </b></text>
<text top="332" left="268" width="8" height="11" font="6"><b>1 </b></text>
<text top="332" left="297" width="8" height="11" font="6"><b>2 </b></text>
<text top="332" left="388" width="8" height="11" font="6"><b>4 </b></text>
<text top="295" left="350" width="13" height="10" font="7"><b>25 </b></text>
<text top="332" left="422" width="8" height="11" font="6"><b>5 </b></text>
<text top="332" left="451" width="8" height="11" font="6"><b>6 </b></text>
</page>
<page number="4" position="absolute" top="0" left="0" height="792" width="612">
<text top="159" left="57" width="57" height="12" font="1">Validation #2 </text>
<text top="171" left="57" width="34" height="12" font="1">Analysis</text>
<text top="643" left="54" width="145" height="12" font="1">Insert Validation Image (Click here)</text>
<text top="698" left="268" width="68" height="10" font="1">Submit by Email</text>
<text top="43" left="130" width="368" height="12" font="1">Comment:  STAT1 and STAT2 are known to homodimerize upon activation by interferon-</text>
<text top="43" left="518" width="33" height="12" font="1">(see for </text>
<text top="55" left="130" width="402" height="12" font="1">example Li et. al., J. Biol. Chem. 271(10);5790-4).   Due to the high level of overlap between peaks </text>
<text top="67" left="130" width="382" height="12" font="1">called from data obtained using antibody sc-345 (STAT1) and antibody sc-476 (STAT2), both </text>
<text top="79" left="130" width="184" height="12" font="1">antibodies meet this criterion for validation. </text>
<text top="91" left="130" width="2" height="12" font="1"> </text>
<text top="103" left="130" width="425" height="12" font="1">We also note that this antibody meets the ENCODE motif enrichment standard for validation based on </text>
<text top="115" left="130" width="417" height="12" font="1">the  9.2-fold enrichment (p-value &lt; 10-172) of a STAT motif in the dataset generated in interferon-  </text>
<text top="127" left="130" width="342" height="12" font="1">stimulated K562 cells. Details can be found in the validation document for sc-345.  </text>
</page>
<page number="5" position="absolute" top="0" left="0" height="612" width="792">
	<fontspec id="8" size="14" family="Times" color="#000000"/>
	<fontspec id="9" size="9" family="Times" color="#000000"/>
	<fontspec id="10" size="9" family="Times" color="#000000"/>
	<fontspec id="11" size="10" family="Times" color="#00a8a9"/>
<text top="115" left="103" width="590" height="18" font="8"><b>Validation 2: Comparison to alternate member of known biochemical complex</b></text>
<text top="108" left="687" width="7" height="27" font="5"> </text>
<text top="136" left="48" width="7" height="27" font="5"> </text>
<text top="178" left="260" width="60" height="13" font="9">Interferon ! </text>
<text top="192" left="265" width="47" height="12" font="9">treatment</text>
<text top="178" left="333" width="40" height="12" font="9">STAT1  </text>
<text top="191" left="322" width="55" height="12" font="9">Peak count</text>
<text top="178" left="393" width="37" height="12" font="9">STAT2 </text>
<text top="191" left="382" width="55" height="12" font="9">Peak count</text>
<text top="178" left="451" width="43" height="12" font="9">Fraction </text>
<text top="191" left="443" width="57" height="12" font="9">overlapping</text>
<text top="206" left="271" width="36" height="12" font="9">30 min.</text>
<text top="206" left="340" width="18" height="12" font="9">258</text>
<text top="206" left="400" width="18" height="12" font="9">427</text>
<text top="206" left="460" width="21" height="12" font="10"><b>0.99</b></text>
<text top="218" left="278" width="22" height="12" font="9">6 hr.</text>
<text top="218" left="340" width="18" height="12" font="9">344</text>
<text top="218" left="400" width="18" height="12" font="9">610</text>
<text top="218" left="468" width="6" height="12" font="10"><b>1</b></text>
<text top="311" left="57" width="663" height="14" font="3">K562 cells treated with Interferon-α for the indicated times were used for ChIP-seq with antibody sc-345 (STAT1) or antibody </text>
<text top="325" left="57" width="649" height="13" font="3">sc-476 (STAT2).  Peaks were called from replicate experiments using PeakSeq with a .01 q-value.  Comparisons between </text>
<text top="339" left="57" width="487" height="13" font="3">experiments were made according to standard ENCODE replicate comparison parameters (</text>
<text top="354" left="57" width="548" height="13" font="11">http://genome.ucsc.edu/ENCODE/protocols/dataStandards/ChIP_DNase_FAIRE_DNAme_v2_2011.pdf</text>
<text top="354" left="605" width="123" height="13" font="3">; reported above is the </text>
<text top="368" left="57" width="680" height="13" font="3">fraction of the  top 40% of STAT1 peaks that are found in the full list of STAT2 peaks.  The reciprocal comparison was made with </text>
<text top="383" left="57" width="97" height="13" font="3">similar results.).    </text>
</page>
</pdf2xml>
